Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythromycin-resistant group G streptococci in an isolated northern Canadian community.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Pyuria in institutionalized elderly subjects.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Prevalence of antibody to hepatitis C virus in an isolated Canadian Inuit settlement.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Infectious diseases on a general internal medicine clinical teaching unit.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Invasive fungal infections in Canada from 1992 to 1994.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Molecular epidemiology of Legionella pneumophila infection at a Canadian tertiary care institution.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same journal

Enterococcus faecalis endocarditis following percutaneous manipulation of a biliary tract calculus and ERCP.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same journal

Infective endocarditis due to Eikenella corrodens: Case report and review of the literature.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same journal

Survey of Neisseria gonorrhoeae antimicrobial susceptibility in Ontario.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same journal

Diagnosis of cellulitis in the immunocompromised host.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same journal

The cost of health care for AIDS patients in Saskatchewan.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same journal

A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
See all related articles

Related Experiment Video

Updated: May 24, 2026

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Vaccine development in Canada

L Nicolle1

  • 1Winnipeg, Manitoba.

The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses
|February 21, 2012
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Related Experiment Videos

Last Updated: May 24, 2026

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013